Teva Migraine Drug Ajovy Wins FDA Approval
Teva Pharmaceutical Industries Ltd. won U.S. regulatory approval to sell a new treatment for migraines, a key part of the [...]
FDA Approves Aimovig for Migraine Prevention
The U.S. Food and Drug Administration has approved erenumab (Aimovig™, Amgen and Novartis), a first-in-class calcitonin gene-related peptide (CGRP) antagonist, [...]